FIORILLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.713
AS - Asia 2.629
EU - Europa 1.344
SA - Sud America 703
AF - Africa 184
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 7.588
Nazione #
US - Stati Uniti d'America 2.591
SG - Singapore 1.033
BR - Brasile 523
CN - Cina 518
IT - Italia 433
VN - Vietnam 404
UA - Ucraina 240
DE - Germania 215
BD - Bangladesh 139
HK - Hong Kong 109
FR - Francia 101
IN - India 75
SN - Senegal 73
AR - Argentina 70
SE - Svezia 65
KR - Corea 62
CA - Canada 58
FI - Finlandia 55
TR - Turchia 51
AT - Austria 46
IQ - Iraq 44
MX - Messico 41
ZA - Sudafrica 41
GB - Regno Unito 39
RU - Federazione Russa 33
ID - Indonesia 29
CO - Colombia 20
EC - Ecuador 20
PK - Pakistan 20
MA - Marocco 19
PL - Polonia 19
VE - Venezuela 19
NL - Olanda 18
JP - Giappone 17
MY - Malesia 16
BE - Belgio 13
CL - Cile 13
PY - Paraguay 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
ES - Italia 11
SA - Arabia Saudita 11
EG - Egitto 10
IL - Israele 10
PE - Perù 10
AU - Australia 9
KE - Kenya 9
PH - Filippine 9
JO - Giordania 8
TN - Tunisia 8
BG - Bulgaria 7
BO - Bolivia 7
DZ - Algeria 7
NP - Nepal 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
UY - Uruguay 6
IE - Irlanda 5
IR - Iran 5
LB - Libano 5
PS - Palestinian Territory 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
ET - Etiopia 4
EU - Europa 4
KZ - Kazakistan 4
LT - Lituania 4
AL - Albania 3
AZ - Azerbaigian 3
HU - Ungheria 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MK - Macedonia 2
MT - Malta 2
NG - Nigeria 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BN - Brunei Darussalam 1
BW - Botswana 1
CM - Camerun 1
DM - Dominica 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
Totale 7.572
Città #
Singapore 419
Chandler 292
San Jose 233
Dallas 197
Ashburn 183
New York 157
Beijing 144
Ho Chi Minh City 137
Jacksonville 137
Boardman 134
Hong Kong 108
Hanoi 103
Council Bluffs 83
San Mateo 83
Dakar 73
Dearborn 67
Rende 65
Seoul 62
Shanghai 60
Lauterbourg 53
Los Angeles 50
Hefei 47
Lawrence 44
Roxbury 44
São Paulo 40
Helsinki 39
Brooklyn 33
Munich 33
Florence 29
Da Nang 28
Vienna 28
Izmir 26
Santa Clara 26
Rio de Janeiro 24
Baghdad 23
Rome 23
Des Moines 22
Ottawa 22
Seattle 21
The Dalles 20
Catanzaro 19
Frankfurt am Main 19
Naples 19
Milan 18
Mexico City 16
Tokyo 16
Cosenza 15
Haiphong 15
Cambridge 14
Chennai 14
Hải Dương 14
Brussels 13
Columbus 13
Inglewood 13
Johannesburg 13
Montreal 13
San Francisco 13
Toronto 13
Warsaw 13
Bari 12
Orem 12
Turku 12
Wilmington 12
Biên Hòa 11
Buffalo 11
Dhaka 11
Guangzhou 11
Ogden 11
Porto Alegre 11
Guarulhos 10
Hanover 10
Palermo 10
Tashkent 10
Turin 10
Amsterdam 9
Boston 9
Kuala Lumpur 9
New Delhi 9
Stockholm 9
Belo Horizonte 8
Catania 8
Falkenstein 8
Manchester 8
Amman 7
Ann Arbor 7
Bremen 7
Caracas 7
Chicago 7
Juiz de Fora 7
London 7
Medellín 7
Ninh Bình 7
Phoenix 7
Pune 7
Tianjin 7
Atlanta 6
Cairo 6
Grafing 6
Guayaquil 6
Lahore 6
Totale 4.050
Nome #
Polyunsaturated Fatty Acids and their Role in the Diet of Cancer Patients: An Overview 234
Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway 212
Bergamot (citrus bergamia risso) flavonoids and their potential benefits in human hyperlipidemia and atherosclerosis: An overview 202
5-(Carbamoylmethylene)-oxazolidin-2-ones as a Promising Class of Heterocycles Inducing Apoptosis Triggered by Increased ROS Levels and Mitochondrial Dysfunction in Breast and Cervical Cancer 201
Bergamot natural products eradicate cancer stem cells (CSCs) by targeting mevalonate, Rho-GDI-signalling and mitochondrial metabolism 199
Estrogen related receptor a (ERRa) a promising target for the therapy of adrenocortical carcinoma (ACC) 193
A Picrocrocin-Enriched Fraction from a Saffron Extract Affects Lipid Homeostasis in HepG2 Cells through a Non-Statin-like Mode 190
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer 185
17-Hydroxyprogesterone/Progesterone Receptor B Signalling Disrupts the Metabolic Reprogramming in Breast Cancer Cell Lines 184
Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs) 172
Enhanced cellular uptake by "pharmaceutically oriented devices" of new simplified analogues of Linezolid with antimicrobial activity 167
Antibacterial activity of new Beta-lactam compounds 159
ERRα/PGC1α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical carcinoma (ACC). 158
ERRα/PGC1-α signaling pathway, which governs mitochondrial biogenesis, could represent a promising target for the therapy of adrenocortical cancer (ACC) 153
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 153
Sericin/Poly(ethylcyanoacrylate) Nanospheres by Interfacial Polymerization for Enhanced Bioefficacy of Fenofibrate: In Vitro and In Vivo Studies 152
ERRα PATHWAY AND ENDOCRINE RESISTANCE ON BREAST CANCER: CHOLESTEROL AND MEVALONATE INVOLVEMENT 150
Characterization of new mitochondrial carriers in Drosophila melanogaster”. 148
Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy 147
Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast 143
Exploiting Glycyrrhiza glabra L. (Licorice) Flavanones: Licoflavanone’s Impact on Breast Cancer Cell Bioenergetics 141
Estrogen Related Receptor α (ERRα) A Promising Target for the Therapy of Adrenocortical Carcinoma (ACC). 134
Foxo3a re-expression overcomes tamoxifen resistance in breast cancer 127
Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production 125
Hypocholesterolaemic activity of 3-hydroxy-3-methyl-glutaryl flavanones enriched fraction from bergamot fruit (Citrus bergamia): "In vivo" studies 120
Thioalbamide, a thioamidated peptide from Amycolatopsis alba, affects tumor growth and stemness by inducing metabolic dysfunction and oxidative stress 120
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple‐negative breast cancer (TNBC) cells 119
New insights about the structural rearrangements required for substrate translocation in the bovine mitochondrial oxoglutarate carrier 118
New insights into cholesterol-mediated ERRα activation in breast cancer progression and pro-tumoral microenvironment orchestration 116
Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells 116
Doxycycline, Azithromycin and vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs) 116
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma 110
The Omega-3 Docosahexaenoyl Ethanolamide Reduces CCL5 Secretion in Triple Negative Breast Cancer Cells Affecting Tumor Progression and Macrophage Recruitment 110
GENOMICS-BASED DISCOVERY AND ANTICANCER ACTIVITY ASSESSMENT OF NEW THIOVIRIDAMIDE-LIKE MOLECULES PRODUCED BY ACTINOBACTERIA 109
"Energetic" cancer stem cells (e-CSCs): A new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy 109
FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity 107
Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase 107
Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells 106
Graphene oxide selectively targets cancer stem cells, across multiple tumor types: Implications for non-toxic cancer treatment, via "differentiation-based nano-therapy" 106
Two functionally different mitochondrial phosphate carriers support Drosophila melanogaster OXPHOS throughout distinct developmental stages 101
A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX 99
Oxazolidinones-mediated mitochondrial dysfunction promotes cell death and cancer stemness inhibition in breast and cervical cancer 97
Impact of COVID-19 Lockdown on Metabolic/Inflammatory Profile in Adolescents: Cellular Studies and Predictive Biomarkers 95
Mass Spectrometry-Based Proteomic Approach in Oenococcus oeni Enological Starter 95
Thioalbamide inhibits FoF1-ATPase in breast cancer cells and reduces tumor proliferation and invasiveness in breast cancer in vivo models 92
Role of ERRα in ACC as potential target for new adrenocortical cancer therapy. 91
Multifunctional Microspheres Based on D-Mannose and Resveratrol for Ciprofloxacin Release 89
Novel CD44-Targeted Albumin Nanoparticles: An Innovative Approach to Improve Breast Cancer Treatment 87
Sntesi ed attività antimicrobica di nuovi derivati b-lattamici 81
Merging fusogenic DOPE and a tumour targeted self-assembling biopolymer: Smart hybrid liposomes for drug vectorization in cancer therapy 80
New Oxazolidin-2-ones of antimicrobial activity 78
Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer 75
High ATP Production Fuels Cancer Drug Resistance and Metastasis: Implications for Mitochondrial ATP Depletion Therapy 75
New β-Lactam derivatives: synthesis and antimicrobial properties. 72
New Oxazolidin-2-ones with antimicrobial activity 71
New simplified analogues of linezolid with antimicrobial activity. 69
The ER-alpha mutation Y537S confers Tamoxifen-resistance via enhanced mitochondrial metabolism, glycolysis and Rho-GDI/PTEN signaling: Implicating TIGAR in somatic resistance to endocrine therapy 67
Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling 63
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer 58
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity 58
Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy 55
Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia 51
Hallmarks of the cancer cell of origin: Comparisons with "energetic" cancer stem cells (e-CSCs) 50
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics 47
Adipocyte‑derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross‑talk between cancer cells and the tumor microenvironment 26
Biomarkers of multimorbidity: A systematic review 25
Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor–Positive Breast Cancer Cells 20
Relapse Despite MRD Negativity in Multiple Myeloma: Toward Integrated Risk Prediction 17
Harnessing the novel safeguarding role of Selenoprotein T in age-related myocardial left and right decline through the ferroptosis-mitochondrial axis 15
Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration 14
Ph‐Negative Acute Lymphoblastic Leukemia in the Older Adults: Biology, Therapeutic Strategies and Unmet Needs 12
Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells 8
ESR1-Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer 1
The Gut Microbiota in Hematologic Malignancies: Mechanisms, Clinical Associations, and Translational Opportunities 1
Totale 7.753
Categoria #
all - tutte 40.832
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.832


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022466 9 61 2 20 45 9 2 98 21 3 68 128
2022/2023774 100 80 21 79 103 55 13 111 95 27 59 31
2023/2024595 67 20 35 16 31 183 21 29 62 33 16 82
2024/20251.247 86 149 19 74 79 74 90 73 192 88 112 211
2025/20263.982 418 237 346 287 582 244 462 224 306 304 331 241
Totale 7.753